Gothenburg, Sweden

Hadi Valadi

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Codiak Biosciences, Inc., Vl27, Inc.. Active years: 2015-2020.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Gothenburg, SE (2018)
  • Göteborg, SE (2015 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hadi Valadi: Innovator in Gene Modulation

Introduction

Hadi Valadi is a prominent inventor based in Gothenburg, Sweden. He has made significant contributions to the field of gene modulation through his innovative research and patents. With a total of 4 patents, Valadi is recognized for his work in advancing therapeutic methods that utilize exosomes for nucleic acid transfer.

Latest Patents

Valadi's latest patents focus on the methods for introducing nucleic acids to cells via exosomes. These methods are designed for use in gene modulation and therapy, including applications for gene silencing. His work aims to introduce genetic material into cells to compensate for abnormal genes or to induce or repress specific processes in the recipient cell.

Career Highlights

Throughout his career, Hadi Valadi has worked with notable companies such as Codiak Biosciences, Inc. and Vl27, Inc. His expertise in the field has allowed him to contribute to groundbreaking research and development in gene therapy.

Collaborations

Valadi has collaborated with esteemed colleagues, including Jan Lötvall and Jan Olof Lötvall, further enhancing the impact of his work in the scientific community.

Conclusion

Hadi Valadi's innovative contributions to gene modulation through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…